Custom Search Insider Trading Activity Insider Trading Activity
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Custom Search Insider Trading Activity
Updated Jun 14, 2024
Ticker
|
Company Name
|
Qty.
|
Price
|
Size ($)
|
Filing Date
|
Type
|
Δ Own
|
Own
|
Insider Names
|
Title
|
Trade Dates
|
Is Scheduled
| |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Biocryst Pharmaceuticals Inc
| 6.82K |
—
|
—
| +23.03% | 36.43K |
Jun 12
| |||||||
Biocryst Pharmaceuticals Inc
| 16.75K |
—
|
—
| +130.15% | 29.61K |
Jun 13
| |||||||
Biocryst Pharmaceuticals Inc
| 12.87K |
—
|
—
|
∞
| 12.87K |
Jun 7
| |||||||
Biocryst Pharmaceuticals Inc
|
0
|
$7.18 | -$38,600.00 |
—
|
0
|
Apr 18
|
Scheduled
| ||||||
Biocryst Pharmaceuticals Inc
|
0
|
$10.91 | -$75,900.00 |
—
|
0
|
Feb 15
|
Scheduled
| ||||||
Biocryst Pharmaceuticals Inc
|
0
|
$7.80 | -$44,750.00 |
—
|
0
|
Nov 15
|
Scheduled
| ||||||
Biocryst Pharmaceuticals Inc
|
0
|
$8.85 | -$62,150.00 |
—
|
0
|
Sep 15
|
Scheduled
| ||||||
Biocryst Pharmaceuticals Inc
| -3.00K |
$8.98 | -$913,950.00 | -100.00% |
0
|
Sep 10
| |||||||
Biocryst Pharmaceuticals Inc
|
0
|
$9.16 | -$65,300.00 |
—
| 3K |
Jul 15
|
Scheduled
| ||||||
Biocryst Pharmaceuticals Inc
|
0
|
—
|
—
|
—
|
0
|
May 25
| |||||||
Biocryst Pharmaceuticals Inc
|
0
|
$8.27 | -$75,137.09 |
—
| 3K |
May 24
|
Scheduled
| ||||||
Biocryst Pharmaceuticals Inc
| -7.00K |
$12.70 | -$88,900.00 | -70.00% | 3K |
May 10
| |||||||
Biocryst Pharmaceuticals Inc
|
0
|
—
|
—
|
—
|
0
|
May 12
| |||||||
Brickell Biotech, Inc.
|
0
|
—
|
—
|
—
|
0
|
Feb 14
| |||||||
Brickell Biotech, Inc.
|
0
|
—
|
—
|
—
|
0
| ||||||||
Brickell Biotech, Inc.
|
0
|
—
|
—
|
—
|
0
| ||||||||
Biocryst Pharmaceuticals Inc
|
0
|
—
|
—
|
—
|
0
|
May 29
| |||||||
Innoviva, Inc.
| -13.68K |
$14.09 | -$192,814.40 | -4.57% | 285.48K |
Aug 20 - Aug 21
|
Scheduled
| ||||||
Biocryst Pharmaceuticals Inc
|
0
|
—
|
—
|
—
|
0
|
Jun 20
| |||||||
Innoviva, Inc.
| -12.68K |
$14.50 | -$183,512.78 | -2.06% | 604.39K |
May 20 - May 21
| |||||||
Innoviva, Inc.
| 74.44K |
—
|
—
| +31.61% | 309.92K |
Mar 2
| |||||||
Innoviva, Inc.
| -23.50K |
$16.46 | -$386,920.00 | -9.07% | 235.47K |
Feb 20 - Feb 21
|
Scheduled
| ||||||
Innoviva, Inc.
| -8.57K |
$13.22 | -$113,370.02 | -3.21% | 258.65K |
Nov 20 - Nov 21
|
Scheduled
| ||||||
Innoviva, Inc.
| -2.89K |
$12.28 | -$35,440.08 | -1.07% | 267.22K |
Aug 20
| |||||||
Biocryst Pharmaceuticals Inc
|
0
|
—
|
—
|
—
|
0
|
May 24
| |||||||
Innoviva, Inc.
| -2.23K |
$11.86 | -$26,424.08 | -0.82% | 270.11K |
May 20
| |||||||
Innoviva, Inc.
| -5.36K |
$12.04 | -$64,474.20 | -1.95% | 269.84K |
Feb 20
| |||||||
Innoviva, Inc.
| 106.72K |
—
|
—
| +63.34% | 275.19K |
Jan 17
| |||||||
Innoviva, Inc.
| -1.27K |
$10.91 | -$13,888.43 | -0.75% | 168.47K |
Nov 20
| |||||||
Innoviva, Inc.
| -1.94K |
$11.79 | -$22,860.81 | -1.13% | 169.46K |
Aug 20
| |||||||
Biocryst Pharmaceuticals Inc
|
0
|
—
|
—
|
—
|
0
|
May 23
| |||||||
Innoviva, Inc.
| -1.28K |
$11.09 | -$14,150.84 | -0.74% | 171.4K |
May 20
| |||||||
Innoviva, Inc.
| -5.38K |
$12.28 | -$66,017.28 | -3.06% | 170.18K |
Feb 19
| |||||||
Innoviva, Inc.
| 92.59K |
—
|
—
| +111.59% | 175.55K |
Jan 14
| |||||||
Biocryst Pharmaceuticals Inc
|
0
|
—
|
—
|
—
|
0
|
May 20
| |||||||
Theravance Inc
| 71.43K |
—
|
—
| +714.29% | 81.43K | +1 |
Jan 7
| ||||||
Theravance Inc
| 10K |
—
|
—
|
∞
| 10K | +1 |
Jun 19
| ||||||
Theravance Inc
|
0
|
—
|
—
|
—
|
0
| +1 | |||||||
Biocryst Pharmaceuticals Inc
|
0
|
—
|
—
|
—
|
0
|
May 2
| |||||||
Biocryst Pharmaceuticals Inc
| 4K |
$1.71 | $6,840.00 | +66.67% | 10K |
Mar 31
| |||||||
It looks like there's no data for these filter options. Maybe you'll be interested in these options instead. | |||||||||||||
Want to view more results?
Unlock the hidden results with your Benzinga Account now. No purchase required.